NCT00005605View on ClinicalTrials.gov

Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Breast CancerOsteoporosis
Trial Locations (1)

60611

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00005605 - Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer | Biotech Hunter | Biotech Hunter